"The U.S. Food and Drug Administration today approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1 form of Gaucher disease, a rare genetic disorder.
Gaucher disease occurs in people who do not produce e"...
Severe hypersensitivity reaction to siltuximab or any of the excipients in SYLVANT.
Last reviewed on RxList: 5/12/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Sylvant Information
Report Problems to the Food and Drug Administration
Find out what women really need.